CrushSCI.com
73.3Average days
65.5Median days
8Fastest days
173Longest days
762025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

34 days

Novel compound heterozygous variant of TOE1 results in a mild type of pontocerebellar hypoplasia type 7: an expansion of the clinical phenotype

Authors
Hongzhu Chen; Niu Li; Yufei Xu; Guoqiang Li; Cui Song; Ru-en Yao; Tingting Yu; Jian Wang; Lin YangShow moreShow less
Affiliations
1. Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; 2. Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics, Shanghai, People’s Republic of China; 3. Shanghai Clinical Research Center for Rare Pediatric Diseases, Shanghai, People’s Republic of China; 4. Department of Endocrinology and Genetic Metabolism Disease, Children’s Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 5. Department of Clinical laboratory, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of ChinaShow moreShow less
Source PDF DOI Publisher page
89 days

Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes

Authors
Raffaella Brugnoni; Eleonora Canioni; Massimiliano Filosto; Antonella Pini; Paola Tonin; Tommaso Rossi; Carlotta Canavese; Marica Eoli; Gabriele Siciliano; Giuseppe Lauria; Renato Mantegazza; Lorenzo MaggiShow moreShow less
Affiliations
1. Neurology IV Unit, Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 2. Department of Clinical and Experimental Sciences, University of Brescia, NeMO-Brescia Clinical Center for Neuromuscular Diseases, Brescia, Italy; 3. Neuromuscular Pediatric Unit, IRCCS Istituto Delle Scienze Neurologiche of Bologna, Bologna, Italy; 4. Neurological Clinic, University of Verona, Verona, Italy; 5. INRCA, Istituto Nazionale Di Ricovero E Cura Per Anziani, Ancona, Italy; 6. Child and Adolescent Neuropsychiatry Unit, University of Torino, Torino, Italy; 7. Molecular Neuro-Oncology Unit, IRCCS-Fondazione Istituto Neurologico Carlo Besta, Milan, Italy; 8. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 9. Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 10. Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, ItalyShow moreShow less
Source PDF DOI Publisher page
40 days

Polygenic variants related to familial hypobetalipoproteinemia in a patient with Alzheimer’s disease homozygotic for the APOE ε2 allele presenting multiple cortical superficial siderosis and recurrent lobar hemorrhages

Authors
Masaki Ikeda; Koichi Okamoto; Keiji Suzuki; Masakuni Amari; Eriko Takai; Masamitsu Takatama; Hideaki Yokoo; Shun Ishibashi; Yoshio IkedaShow moreShow less
Affiliations
1. Division of General Education (Neurology), Faculty of Health & Medical Care, Saitama Medical University, Hidaka, Japan; 2. Department of Neurology, Geriatrics Research Institute and Hospital, Maebashi, Japan; 3. Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan; 4. Department of Pathology, Geriatrics Research Institute and Hospital, Maebashi, Japan; 5. Department of Internal Medicine, Geriatrics Research Institute and Hospital, Maebashi, Japan; 6. Department of Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan; 7. Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University, Shimotsukeshi, Tochigi, JapanShow moreShow less
Source PDF DOI Publisher page
35 days

FUS mutations dominate TBK1 mutations in FUS / TBK1 double-mutant ALS/FTD pedigrees

Authors
David Brenner; Kathrin Müller; Serena Lattante; Rüstem Yilmaz; Antje Knehr; Axel Freischmidt; Albert C. Ludolph; Peter M. Andersen; Jochen H. WeishauptShow moreShow less
Affiliations
1. Division of Neurodegeneration, Department of Neurology, Mannheim Center for Translational Neurosciences (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 2. Department of Neurology, University of Ulm, Ulm, Germany; 3. Section of Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy; 4. Unit of Medical Genetics, Department of Laboratory and Infectious Disease Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; 5. Department of Clinical Sciences, Neurosciences, Umeå University, Umeå, SwedenShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.